These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 26549782)

  • 1. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.
    Morrow JM; Sinclair CD; Fischmann A; Machado PM; Reilly MM; Yousry TA; Thornton JS; Hanna MG
    Lancet Neurol; 2016 Jan; 15(1):65-77. PubMed ID: 26549782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle fat quantification using magnetic resonance imaging: case-control study of Charcot-Marie-Tooth disease patients and volunteers.
    Kim HS; Yoon YC; Choi BO; Jin W; Cha JG
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):574-585. PubMed ID: 30873759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower limb muscle MRI fat fraction is a responsive outcome measure in CMT X1, 1B and 2A.
    Doherty CM; Morrow JM; Zuccarino R; Howard P; Wastling S; Pipis M; Zafeiropoulos N; Stephens KJ; Grider T; Feely SME; Nopoulous P; Skorupinska M; Milev E; Nicolaisen E; Dudzeic M; McDowell A; Dilek N; Muntoni F; Rossor AM; Shah S; Laura M; Yousry TA; Thedens D; Thornton J; Shy ME; Reilly MM
    Ann Clin Transl Neurol; 2024 Mar; 11(3):607-617. PubMed ID: 38173284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of MRC Centre MRI calf muscle fat fraction protocol as a sensitive outcome measure in Hereditary Sensory Neuropathy Type 1.
    Kugathasan U; Evans MRB; Morrow JM; Sinclair CDJ; Thornton JS; Yousry TA; Hornemann T; Suriyanarayanan S; Owusu-Ansah K; Lauria G; Lombardi R; Polke JM; Wilson E; Bennett DLH; Houlden H; Hanna MG; Blake JC; Laura M; Reilly MM
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):895-906. PubMed ID: 30995999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Year Longitudinal Assessment of Patients With CMT1A Using Quantitative MRI.
    Fortanier E; Hostin MA; Michel C; Delmont E; Bellemare ME; Guye M; Bendahan D; Attarian S
    Neurology; 2024 May; 102(9):e209277. PubMed ID: 38630962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle MRI magnetisation transfer ratio reflects clinical severity in peripheral neuropathies.
    Sinclair CD; Morrow JM; Miranda MA; Davagnanam I; Cowley PC; Mehta H; Hanna MG; Koltzenburg M; Yousry TA; Reilly MM; Thornton JS
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):29-32. PubMed ID: 21613652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A.
    Morrow JM; Evans MRB; Grider T; Sinclair CDJ; Thedens D; Shah S; Yousry TA; Hanna MG; Nopoulos P; Thornton JS; Shy ME; Reilly MM
    Neurology; 2018 Sep; 91(12):e1125-e1129. PubMed ID: 30120135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis.
    Laurent D; Riek J; Sinclair CDJ; Houston P; Roubenoff R; Papanicolaou DA; Nagy A; Pieper S; Yousry TA; Hanna MG; Thornton JS; Machado PM
    Neurology; 2022 Aug; 99(9):e865-e876. PubMed ID: 36038279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study.
    Berciano J; Gallardo E; García A; Infante J; Mateo I; Combarros O
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1169-76. PubMed ID: 16788010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Charcot-Marie-Tooth Disease Type 4J.
    Sadjadi R; Picher-Martel V; Morrow JM; Thedens D; DiCamillo PA; McCray BA; Pareyson D; Herrmann DN; Reilly MM; Li J; Castro D; Shy ME;
    Neurology; 2024 Sep; 103(5):e209763. PubMed ID: 39133880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Foot Muscle Magnetic Resonance Imaging Reliably Measures Disease Progression in Children and Adolescents with Charcot-Marie-Tooth Disease Type 1A.
    Doherty CM; Howard P; O'Donnell LF; Zuccarino R; Wastling S; Milev E; Banks T; Shah S; Zafeiropoulos N; Stephens KJ; Sarkozy A; Grider T; Feely SME; Manzur A; Shy RR; Skorupinska M; Pipis M; Nicolaisen E; McDowell A; Dilek N; Rossor AM; Laura M; Clark C; Muntoni F; Thedens D; Thornton J; Morrow JM; Shy ME; Reilly MM
    Ann Neurol; 2024 Jul; 96(1):170-174. PubMed ID: 38613459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraepidermal nerve fibre density as biomarker in Charcot-Marie-Tooth disease type 1A.
    Hartmannsberger B; Doppler K; Stauber J; Schlotter-Weigel B; Young P; Sereda MW; Sommer C
    Brain Commun; 2020; 2(1):fcaa012. PubMed ID: 32954280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative MRI outcome measures in CMT1A using automated lower limb muscle segmentation.
    O'Donnell LF; Pipis M; Thornton JS; Kanber B; Wastling S; McDowell A; Zafeiropoulos N; Laura M; Skorupinska M; Record CJ; Doherty CM; Herrmann DN; Zetterberg H; Heslegrave AJ; Laban R; Rossor AM; Morrow JM; Reilly MM
    J Neurol Neurosurg Psychiatry; 2024 May; 95(6):500-503. PubMed ID: 37979968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.
    Eichinger K; Sowden JE; Burns J; McDermott MP; Krischer J; Thornton J; Pareyson D; Scherer SS; Shy ME; Reilly MM; Herrmann DN
    Front Neurol; 2022; 13():930435. PubMed ID: 35832173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests.
    Nuñez-Peralta C; Montesinos P; Alonso-Jiménez A; Alonso-Pérez J; Reyes-Leiva D; Sánchez-González J; Llauger-Roselló J; Segovia S; Belmonte I; Pedrosa I; Martínez-Noguera A; Matellini-Mosca B; Walter G; Díaz-Manera J
    Front Neurol; 2021; 12():634766. PubMed ID: 33796064
    [No Abstract]   [Full Text] [Related]  

  • 20. Correcting radiofrequency inhomogeneity effects in skeletal muscle magnetisation transfer maps.
    Sinclair CD; Morrow JM; Hanna MG; Reilly MM; Yousry TA; Golay X; Thornton JS
    NMR Biomed; 2012 Feb; 25(2):262-70. PubMed ID: 21796708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.